A distinct approach to scaling new battery technology

Ilika Plc

Ilika plc operates with a clear-eyed recognition of how to extract value from the solid-state battery sector without the direct capital and operational risks associated with traditional manufacturing expansion. Ilika has focused attention on cultivating two product lines: Stereax batteries, designed for the compact and demanding needs of medical devices and wireless sensors, and Goliath batteries, targeting large-format applications such as electric vehicles and consumer appliances.

Stereax, their micro-battery technology, has recently transitioned to commercial production under a ten-year agreement with Cirtec Medical in the US. This partnership moves Ilika from technical development to the delivery phase, with the first batches now scheduled for lead customers. The process milestone, achieved through technical validation at Cirtec’s facility, underscores not just the versatility of Stereax but also the company’s commitment to meeting stringent industry requirements, particularly in medical devices where size, safety, and reliability dominate procurement choices.

The Goliath business, meanwhile, focuses on scaling up production for automotive and consumer use through a highly automated pilot line. The recent installation and commissioning of new equipment not only boosts output but brings a level of process consistency that is essential for meeting customer validation protocols and de-risking future industrial ramp-ups. –

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search